Clinical Trial Update: Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC [Phase 2]

View source ↗

Summary

The document describes a Phase 2 clinical trial evaluating pemetrexed with or without carboplatin as second-line treatment for advanced non-small cell lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica | Conditions: Advanced Non-Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN